Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.
about
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in miceA mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2Nucleotide sequence of streptococcal pyrogenic exotoxin type CToxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.Characterization of novel type C staphylococcal enterotoxins: biological and evolutionary implications.A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and CA single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.
P2860
Q30802758-8E3A22B0-4C67-4742-8AFC-2CD8F40650E3Q33558510-AE9552CE-212A-46E8-B99A-AF6DE83C2CC5Q33719201-60B0B10F-9B9A-4B81-9B35-0B29FCE19646Q34004630-77CC37D5-6FDB-4A62-A239-C9CC817178CAQ34123551-C19FC5DD-8E37-4803-BD8E-AEEBB1CC8E49Q35088293-13981A45-CB04-4FF3-89BA-B05FC62B1B2CQ35112213-55AECB97-0E22-432F-B740-327653CEFFA5Q36999391-B8181121-6C3F-4928-AA59-134FE5F9D8F0Q39537840-915B3A8A-0157-496C-A652-6399DF0CB460Q39821625-DAD62E07-ECC6-456A-9641-30A9907F44E2Q40149402-A9684230-7786-4A12-A913-6962FC83CD82Q40269012-2EF7BC13-9115-42D9-8ECF-CF7D29D12CAFQ40339206-3A8C5AC2-1C6C-4E05-AAF6-AE0570D805E9Q42376180-046BBB58-B874-495D-B566-B64B2EAB63BB
P2860
Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Cross-neutralization of staphy ...... nal and polyclonal antibodies.
@en
type
label
Cross-neutralization of staphy ...... nal and polyclonal antibodies.
@en
prefLabel
Cross-neutralization of staphy ...... nal and polyclonal antibodies.
@en
P2093
P2860
P1476
Cross-neutralization of staphy ...... nal and polyclonal antibodies.
@en
P2093
G A Bohach
J P Handley
P M Schlievert
P2860
P304
P407
P577
1988-02-01T00:00:00Z